Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02845102 · ClinicalTrials.gov registry record · NA
Treating Comorbid Depression During Care Transitions Using Relational Agents
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02845102 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT02845102, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Depression is common among individuals with chronic illness such as chronic heart failure (CHF) or chronic obstructive pulmonary disease (COPD) and is a strong predictor of poor clinical outcomes and high rates of avoidable 30-day readmissions. While depression is a treatable condition, few people with depression receive effective treatment. The proposed study aims to develop a relational agent system to deliver depression treatment to patients with chronic illness and comorbid depression. While depression is a treatable condition, less than 36% of people with depression receive effective treatment. The proposed study aims to design and develop a technology-driven relational agent system to deliver a 6 module, blended approach of cognitive behavioral therapy and self-management education (RA-CBT) to support patients with CHF or COPD and comorbid depression. The relational agent is a human animation program that interacts with patients, integrates best practices from provider-patient communication theory, emulating the face-to-face conversational behavior of an empathic provider emphasizing nonverbal communicative behavior such as gaze, posture, gestures, etc. The RA-CBT program will be accessed via tablet technology by participants. The study investigators will conduct a pre-post feasibility study to understand the feasibility and acceptability of using the RA-CBT system and its effectiveness in treating comorbid depression. If successful, this new approach to depression treatment would immediately expand access and scalability for post-discharge mental health support in the care transition.
Interventions
- OTHER Pre-Post Feasibility
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-05-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02845102
The ClinicalTrials.gov registry entry for NCT02845102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pre-Post Feasibility is the first listed.
NCT02845102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02845102 about?
NCT02845102 is a clinical study titled "Treating Comorbid Depression During Care Transitions Using Relational Agents". Depression is common among individuals with chronic illness such as chronic heart failure (CHF) or chronic obstructive pulmonary disease (COPD) and is a strong predictor of poor clinical outcomes and high rates of avoidable 30-day readmissions. While depression is a treatable condition, few people w...
What is the current status of trial NCT02845102?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2014-08. Estimated completion is 2017-05-21.
What interventions are being tested in trial NCT02845102?
The interventions under investigation include: Pre-Post Feasibility (OTHER).
Who is sponsoring clinical trial NCT02845102?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.